Overview

CKD-330 Phase 3 Trial in Amlodipine Non-responder

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

Trial to Evaluate the Efficacy and Safety of a CKD-330 versus Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by Amlodipine Monotherapy

Phase:

Phase 3

Details

Lead Sponsor:

Chong Kun Dang Pharmaceutical

Treatments:

Amlodipine